Profile: Dendreon Corporation is an biotechnology company is developing innovative cancer therapies with a variety of therapeutic process. While each of these process uses distinct mechanisms of action to destroy cancer cells to improve the lives of patients. We are also developing active cellular immunotherapies, small molecules and monoclonal antibodies for a variety of cancers. The pipelines which have been discovered which includes Sipuleucel-T & Lapuleucel-T for active cellular immunotherapy, monoclonal antibody and small molecule product candidates to treat a wide range of cancers.